Drug intelligence / Profile preview

FEM Urovital

Development stage
Unknown
Lead developer
UPSA
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

FEM Urovital is a non-hormonal dietary supplement formulated to support women's urinary health, bladder control, and overall urinary well-being. Developed under the FEM By UPSA brand, which combines the women's health research of Sérélys Pharma with the pharmaceutical heritage of UPSA, the product is designed to address overactive bladder-type symptoms such as urgency, frequency, and occasional leakage. Its formulation features UriCytonin (also known as Pure CyTonin), a patented, purified cytoplasmic pollen extract, combined with pumpkin seed extract and vitamin E. The supplement works naturally to support pelvic floor muscle function and strengthen bladder tone without hormonal activity. It is administered as an oral capsule.

Brand names
FEM UrovitalUPSA FEM UROVITAL
Other names
FEM Urovital with Pure CytoninFEM Urovital with UriCytonin
02

Targets

DRD2 (Dopamine D2 Receptor)TACR3 (Neurokinin 3 Receptor)ESR1 (ERα)

Beyond the preview

Go deeper on FEM Urovital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FEM Urovital.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call